Variables

Responses

Frequency

%

Base line HAART usage

PRE-HAART

HAART

284

550

34.1

65.9

Type of drug regimen

1a (30)

1a (40)

1b (30)

1b (40)

1c

1e

1f

176

3

128

3

60

74

106

21.1

0.4

15.3

0.4

7.2

8.9

12.7

History of Diabetes status

Yes

No

Not known

17

540

277

2.0

64.7

33.2

Incidence of Hypertension

Yes

No

29

736

3.94

95.6

Family History of hypertension

Yes

No

129

705

15.5

84.5

History of UTI

Yes

No

Unknown

76

755

3

9.1

90.5

0.4

WHO Clinical Stage

Stage I

Stage II

Stage III

Stage IV

290

93

398

53

34.8

11.2

47.7

6.4

Base line CD4 lymphocyte Count

500+

200 - 500

<200

267

294

273

32.0

35.3

32.7

Duration of HAART Exposure

Up to 1 year

1 to 5 years

5+ Years

BMI (kg/m²)

<18

18 - 24

25+

171

544

119

20.5

65.2

14.3